Kazakhstan to eliminate preferences for national suppliers of medicinal products

| By | Drug Procurement, EAEU, Kazakhstan

At its meeting on April 28, the Council of the Eurasian Economic Commission discussed the elimination of barriers and restrictions that impede the free movement of goods and services on the internal market of the Eurasian Economic Union (EAEU).

“The Commission continues to work on eliminating obstacles to the free movement of goods, services, capital, and labor in the internal market of the Union,” said Karine Minasyan, Member of the Board – Minister in charge of Internal Markets, Information Support, Information and Communication Technologies of the Eurasian Economic Commission. “The Discussion at the Council level of such issues and adoption of concerted measures to continue removing the obstacles are particularly important since they significantly accelerate their resolution.”

One of the barriers exists in Kazakhstan where the procedure for procurement of drugs, vaccines, and other immunobiological products at the expense of the government budget under the program of guaranteed free medical care is inconsistent with EAEU legislation. In such procurement, the national suppliers are given preferences within bidding procedures. The representatives of Kazakhstan agreed to eliminate this barrier by July 1, 2017.

VIArussian version
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.